40 Participants Needed

GOLD Program for Childhood Cancer Family Support

VE
Overseen ByVictoria E. Cosgrove, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on support for caregivers, so it's unlikely that medication changes are required.

What data supports the effectiveness of the GOLD Program treatment for families of youth with cancer?

Research shows that resilience-promoting programs for families of children with cancer can improve coping skills, reduce anxiety, and enhance family adaptation. These programs often include providing information and emotional coping strategies, which have been linked to better mental health outcomes for both children and their families.12345

Is the GOLD Program for Childhood Cancer Family Support safe for participants?

The research on resilience-promoting programs for families of children with cancer suggests these programs are generally safe, focusing on providing information and emotional coping strategies to improve mental health outcomes like resilience and reduced anxiety.36789

How is the GOLD Program treatment different from other treatments for families of children with cancer?

The GOLD Program is unique because it focuses on reducing anxiety and promoting resilience in families of children with cancer through a brief intervention that includes providing information and emotional coping strategies. Unlike other treatments that may focus solely on the child or medical aspects, this program aims to improve the overall family dynamic and emotional well-being.36101112

Research Team

VE

Victoria E. Cosgrove, PhD

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for primary caregivers of children under 18 recently diagnosed with blood or brain/CNS cancer. Caregivers must be proficient in English and able to consent to research. Children/siblings over age 8 can also participate. Those with active suicidal thoughts or not caring for a child diagnosed within the last six months are excluded.

Inclusion Criteria

Consent to research
I care for a child under 18 recently diagnosed with blood or brain cancer.
I am over 8 years old.

Exclusion Criteria

Anyone who is not a caregiver of children who have been diagnosed with cancer within the past six months will be excluded.
I am currently having thoughts about harming myself.
Lack of proficiency in written and spoken English

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a 2-hour interventional session consisting of psychoeducation and coping, and stress, triggers, and self-care modules

1 session
1 visit (virtual)

Follow-up

Participants are monitored for feasibility, acceptability, and psychological distress symptoms after the intervention

1 month

Treatment Details

Interventions

  • GOLD Program
  • Treatment as usual (TAU)
Trial OverviewThe GOLD Program, a virtual psychotherapeutic and educational intervention, is being tested against the usual treatment methods (TAU) for reducing anxiety and promoting resilience among families of youth with cancer.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: GOLD Psychosocial ProgramExperimental Treatment1 Intervention
Participant will receive a 2-hour interventional session. Its content will consist of two modules: (1) psychoeducation and coping, providing information in content areas such as side effects of cancer treatments, fever protocols, role disruption and (2) stress, triggers, and self care, where caregivers will be briefed on symptoms of and reactions to traumatic stress in order to help parents accurately label thoughts and emotions related to their child's cancer diagnosis.
Group II: Treatment-as-Usual (TAU)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

Findings from Research

A survey of 242 psychosocial providers revealed that psychoeducation is the most commonly offered intervention for children with cancer and their families, regardless of the patient's age or treatment stage.
While evidence-based therapies like cognitive behavioral therapy and mindfulness are frequently used, there is a need for more interventions specifically designed for pediatric oncology, and providers identified barriers such as staffing and communication that hinder quality care.
Utilization of Psychotherapeutic Interventions by Pediatric Psychosocial Providers.Fair, C., Thompson, A., Barnett, M., et al.[2022]
Psychosocial support for children with cancer is crucial from the moment of diagnosis, with effective adaptation linked to the child's understanding of their situation and the emotional support from their family.
Research has shown that parental distress and available social supports significantly impact a child's adjustment to cancer treatment, highlighting the need for comprehensive support programs for both children and their families.
Psychosocial issues during the acute treatment of pediatric cancer.Koocher, GP.[2019]
A systematic review of eight studies identified key components of resilience-promoting programs for children with cancer and their families, including providing information on coping strategies and emotional support.
These programs led to improved resilience and coping skills, as well as reduced symptoms of depression, anxiety, and posttraumatic stress, highlighting their potential to enhance the quality of life for affected families.
Resilience-Promoting Programs in Families of Children With Cancer: A Systematic Review.Park, M., Choi, EK., Lee, HJ., et al.[2022]

References

Utilization of Psychotherapeutic Interventions by Pediatric Psychosocial Providers. [2022]
Psychosocial issues during the acute treatment of pediatric cancer. [2019]
Resilience-Promoting Programs in Families of Children With Cancer: A Systematic Review. [2022]
Review of family-based psychosocial interventions for childhood cancer. [2022]
Treating persistent distress and anxiety in parents of children with cancer: an initial feasibility trial. [2018]
Concerns experienced by parents of children treated for cancer: A qualitative study to inform adaptations to an internet-administered, low-intensity cognitive behavioral therapy intervention. [2023]
Impact of Ego-resilience and Family Function on Quality of Life in Childhood Leukemia Survivors. [2019]
Comprehensive support for families with parental cancer (Family-SCOUT), evaluation of a complex intervention: study protocol for a non-randomized controlled trial. [2021]
The family bereavement program: efficacy evaluation of a theory-based prevention program for parentally bereaved children and adolescents. [2019]
Parents' experiences of a Family Support Program when a parent has incurable cancer. [2022]
Psychological treatment for family members of children with cancer: A systematic review and meta-analysis. [2020]
12.United Statespubmed.ncbi.nlm.nih.gov
Helping the parents of children with malignancy. [2019]